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Cytokines, which collectively include the lymphokines and monokines, represent
a family ofbioactive polypeptides that are secreted in response to appropriate stim-
ulation by a variety ofboth lymphoid and nonlymphoid cells. Distinct cytokines,
through autocrine, paracrine, or endocrine mechanisms, are responsible for the ac-
tivation and propagation of immune responses (1), as well as for coordinating the
maturation ofdifferentcell lineagesofthehematopoietic system (1, 2). It istherefore
not unreasonable to assume that thesynthesisofthe various typesofcytokines must
be under strict regulation at all times, both at the cell and organ levels.
We recently reported that exposure of normal mice to the inflammatory effects
ofUV radiation (UVR), t bacterial LPS, or IL-10 caused a change in the responses
ofT cells from theirperipheral lymphoid organs to antigen or mitogen stimulation
(3). Activated lymphocytes from the spleen or lymph nodes ofexposed donors pro-
duced markedly reduced levels of IL-2 and IFN-y, while simultaneously secreting
elevated quantities of IL-4. These findings are consistent with reported alterations
in immunologic potential observed in UVR, LPS-, or IL-1 treated animals (4-8).
Analysis oftheresponsible mechanism(s) forthiseffect determined thatnormal animals
treated with metyrapone (an 113-hydroxylase inhibitor) (9), or RU486 (apotent glu-
cocorticoid [GC) antagonist) (10), were refractory to inflammation-induced changes
to their T cell growth factor (TCGF) production (Moon, H. B., D. S. Han, B. A.
Araneo, and R. A. Daynes, manuscript submitted for publication). These findings
suggestedthat GCs, secondarilyelevated inresponse to IL-1-mediated effects on the
hypothalamic-pituitary-adrenal axis (11, 12), were in someway responsible for altering
the pattern of TCGF produced by heterogeneous populations of activated T cells
in animals exposed to inflammatory stimuli. Further support for thishypothesis was
derived from studies that demonstrated that enriched populations ofT cells from
normal donors, as well as cloned T cell lines (capable ofboth IL-2 and IL-4produc-
Thesestudieswere supportedby National Institutes of Health grants CA-22126, CA-25917,andCA-33065.
Addresscorrespondence to RaymondA. Daynes, Division ofCell BiologyandImmunology, Univer-
sity of Utah School of Medicine, 50 North Medical Drive, Salt Lake City, UT 84132.
1 Abbreviations used in this paper: DHEA, dehydroepiandrosterone; GC, glucocorticoid; TCGF, T cell
growth factor; UVR, UV radiation.
J. Exp. MED. C The Rockefeller University Press - 0022-1007/90/04/0979/18 $2.00
￿
979
Volume 171 April 1990 979-996980
￿
LYMPHOID TISSUE CONTROL OF INTERLEUKIN
tion after activation), secreted reduced levels of IL-2 and elevated levels of IL-4 sub-
sequent to a direct exposure to physiologic or pharmacologic levels of GCs in vitro
or in vivo (13).
Studies have now determined that dehydroepiandrosterone (DHEA), the major
androgen steroid hormone in humans (14-17), is capable of enhancing the potential
of murine T cells to produce IL-2 subsequent to appropriate activation (18). In ad-
dition to a direct effect on T cells in vitro, DHEA treatment ofnormal or GC-treated
animals resulted in an enhanced capacity of their T cellsto produce IL-2 in response
to antigen or mitogen stimulation.
Herein, we report the results of experiments designed to question the regulatory
control being exerted on T cells in vivo with regards to their capacity to produce
selected lymphokines after activation. Out studies demonstrate that IL-2 represents
the dominant contributor to TCGF activity by mitogen- or antigen-stimulated T
cells isolated from lymphoid organs of normal mice that receive their drainage from
nonmucosal tissue sites. Conversely, IL-4 was found to represent the predominant
TCGF produced by resident T cells obtained from mucosal lymphoid organs, and
peripheral lymph nodes that receive afferent lymphatic drainage from the various
types of mucosal tissues (e.g., salivary gland, lungs, genitourinary tract, and gut).
Further, our results indicate that steroid hormones, produced locally from inactive
precursors, may control the functional potential possessed by T cells that reside in
a given lymphoid compartment.
Materials and Methods
Mice
C3H/HeN and (C3H/HeN x BL/6)F, mice were bred and housed in the University of
Utah Vivarium from breeding stock originally purchased from the National Cancer Institute
(Bethesda, MD). Alternatively, adult C3H/HeN mice were purchased from the National
Cancer Institute, isolated for a minimum of 2 wk upon arrival, and then used in experiments.
Mice used for this study varied between 12 and 24 wk of age. Age-matched animals were
used in each individual experiment, and the number ofmice in a single experimental group
varied between two and eight. The animal facility at the University ofUtah guarantees strict
compliance with regulations established by the Animal Welfare Act.
Antigens and Reagents
Antigens.
￿
OVA used for immunization was purchased from Sigma Chemical Co. (St. Louis,
MO) and used without further modification or purification. The OVA was dissolved in iso-
tonic saline at a concentration of 20 mg/ml and stored at -20°C until required.
Antibodies.
￿
Several mAb reagents were used in the present study. All mAb-containing cul-
ture supernatants were derived from hybridoma cell lines grown in our laboratory. We ob-
tained the anti-IL-2-secreting hybridoma, S4B6, as a gift from T. Mosmann, DNAX (Palo
Alto, CA). The hamster antimurine CD3 mAb-secreting hybridoma (145-2C.11.4.5) was ob-
tained fromJ. Bluestone (University ofChicago). The hybridoma-producing antibody specific
for murine IL-4 (11B11) was purchased from the American Type Culture Collection (Rock-
ville, MD).
Bioactive Compounds.
￿
The GCs and androgen steroids used in our studies were purchased
from Sigma Chemical Co., except for the glucocorticosteroid antagonist, RU486, which was
a gift from Dr. Murray Mitchell at the University of Utah. Each was stored as a stock solution
at 10-2 M in ethanol, and diluted into complete media just before its addition to culture.
Biodegradable corticosterone and RU486 pellets, designed to release their incorporated drug
over a 20-d period, were obtained from Innovative Research (Toledo, OH).
MurineRecombinantILs.
￿
Toprovide us with a source ofrecombinant formsof murine IL-2DAYNES ET AL.
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and IL-4, we obtained X63-IL-2 and X63-IL-4 transfectants from Dr. Fritz Melchers (Basel,
Switzerland). These cell lines were derived from X63Ag8-653, a non-Ig-secreting murine
plasmacytoma, transfected with either a 563-bp cDNA for murine IL-2 or a 500-bp fragment
of the murine IL-4 cDNA (19). X63-IL-2 and X63-IL-4 lines were used to produce condi-
tioned cell culture supernatants containing high titers of IL-2 or IL-4, which were used to
maintain the growth of the IL-2/IL-4-dependent cell line CTLL-2, and to monitor the
specificity of our lymphokine bioassays. Under these culture conditions, maximum sensi-
tivity to both TCGFs was maintained, greatly facilitating the quantitation of IL-2 and IL-4
activities by bioassay.
Bioassays for IL-2 and IL-4
Based on the observation that IL-2 and IL-4, but not IL-1, IL-3, IL-5, orGMCSF, support
viability of the CTLL-2 indicator cell line used in our bioassays, total TCGF activity and
the relative contribution of IL-2 and IL-4 in individual test supernatants could be assessed
by comparing the ability of serial dilutions of test supernatants to maintain the viability of
indicator cell lines in the presence of specific blocking antibodies (20). The ability of a test
supernatant (in the presence or absence of blocking antibodies) to maintain CTLL-2 via-
bility was evaluated by the use of3-[4,5-dimethylthiazole-2-yl]-2,5 diphenyl tetrazolium bro-
mide (MTT) added at a final concentration of 5 gg/ml for the final 2-4 h of a 24-h bioassay
(21). DMSO was added to the culture wells to dissolve the blue formazan crystals, followed
by reading the absorbance of each well at 570 nM with a Titertek Multiscan ELISA reader
(Flow Laboratories, Inc., McLean, VA). Alternatively, cell viability of the indicator cell lines
was evaluated microscopically (22) with the final endpoint being conservatively estimated
as the highest dilution (twofold) of test supernatant allowing >50% viability of the indicator
cells at 24 h. In parallel assays of test supernatants containing known quantities of IL-2 and
IL-4, we have established that the spectrophotometric assay correlates well with the visual
method in determining the relative contribution of IL-2 and IL-4 present in complex test
supernatants. The microscopic method, however, proved to be two- to fourfold more sensitive
than spectrophotometric analysis.
Immunizations and Adoptive Transfers
Mice were immunized with 100 RgofOVAemulsified in CFA. For adoptive transfers, donor
lymphocytes were obtained from the peripheral lymph nodes, spleen, or Peyer's patches of
OVA-primeddonors (4-6 wk post-immunization). Dissociated antigen-primed lymphoid cells
were adoptively transferred intravenously into naive syngeneic recipients. After a 1-wk period,
recipient animals were killed and their lymphoid organs (peripheral lymph nodes, spleen,
mesenteric lymph nodes, and Peyer's patches) were analyzed quantitatively for the patterns
of TCGF (IL-2 and IL-4) secreted by their OVA-specific T cells.
Culture Conditions
Single cell suspensions were prepared from peripheral lymph nodes, spleens, or Peyer's
patches from normal or immunized mice, and cultured at a density of 10' cells/ml either
in 1-ml volumes into 24-well Cluster culture plates (Costar, Cambridge, MA) or in 0.2-ml
volumes in 96-well microtest plates (Falcon Labware, Oxnard, CA). Culture medium con-
sisted ofRPMI 1640 supplemented with 1% Nutridoma-NS (Boehringer Mannheim Biochem-
icals, Indianapolis, IN), antibiotics, 200 MM L-glutamine, and 5 x 10-s M 2-ME. The cul-
tured cells were stimulated with either 100 FAg/ml of OVA or a predetermined optimum
concentration ofanti-CD3, and then incubated for 24 h at 37°C in 10% C02 in a humidified
incubator. Culture supernatants were harvested, clarified by centrifugation, and stored at
-20°C until bioassayed for specific lymphokines.
DHEA Sulfatase Assay
Lymphoid tissues and other tissues types to be analyzed for DHEA-sulfatase activity were
collected from normal mice immediately after cervical dislocation. The individual tissues
were placed into a small volume (200-500 ul) of chilled lysis buffer (5 mM Tris-HCI, 2 mM
EDTA, 7 mM mercaptoethanol, pH 7.5) containing 0.1% Triton X-100 and sonicated on982
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ice(5 s at 50 W, sonifer equipped with amicrotip; Bronson Sonic PowerCo., Danbury, CT).
Protein determinations were made (protein assay; Bio-Rad Laboratories, Richmond, CA)
on the individual homogenates usinga BSA standard, and theprotein concentrationofeach
wasadjusted to 1 mg/mlby the addition of ice-cold lysisbuffer. Amodification of the method
of Ropers et al. (23), was used for determination of DHEA sulfatase activity in the tissue
samples. Data given represents the mean of triplicate samples in picomole of DHEA-sulfate
converted/mg of protein/h.
Results
Lymphocytes Obtainedfrom MucosalandNonmucosalLymphoid Organs ofNormal Animals
ProduceDifferent Patterns of TCGF afterMitogenActivation. Lymphocytes, asceptically
collected from peripheral lymph nodes (axillary, brachial, andinguinal), spleen, mesen-
teric lymph nodes, and Peyer's patches were stimulated with an optimum amount
ofanti-CD3. Cell supernatants were collected after 24 h of incubation at 37°C from
triplicate cultures of each individual tissue, followed by a quantitative bioanalysis
for IL-2 and IL-4. The results (Fig. 1) demonstrate that IL-2 represents the major
species of TCGF produced by anti-CD3-activated lymphocytes obtained from pe-
ripheral lymph nodes and spleen, a findingthat is totally consistent with previously
reported observations made by other investigators (24, 25). Lymphocytes obtained
from the mesenteric lymph nodes, which receive extravasating lymphocytes from
both the blood and from the Peyer's patch drainage, produce approximately equal
activities of IL-2 and IL-4 after in vitro activation. In contrast, lymphocytes ob-
tained from Peyer's patchesofnormal mice produced IL-4 as the predominant spe-
cies ofTCGF after activation with anti-CD3 . Identical experimentsusing a variety
of different mouse strains and activation conditions have been repeated numerous
times with equivalent results. These findings suggested the existence of regulatory
mechanisms that are operativein vivo, that controlthemajor species of TCGF capable
of beingproduced by activatedlymphocytesresident in mucosal or nonmucosal lym-
phoid organs. Such results mightbe explained from either a selectivity in thehoming
behavior oflymphocytes in the recirculating Tcell pool (26), or preferential require-
ments by members of individual T cell subsets for distinct types of APC (27, 28).
Alternatively, however, these results could also be explained through a conservative
mechanismwhere quantitative andqualitative potentials fortheproduction of selected
lymphokines (e.g., TCGF) are microenvironmentally provided to individual recir-
culating lymphocytes during their brief residence within a particular type of lym-
phoid organ. The objective ofthe present investigation was to evaluate these possi-
bilities and provide evidence that strongly favors the hypothesis that the types and
quantities of lymphokines produced by individual activatedlymphocytes areunder
controlling influences provided during residence within aparticular lymphoid organ.
GCs and GC Antagonists are Capable of Altering the Capacity ofActivated T Cellsfrom
allLymphoid Organs to ProduceIL-2 andIL-4. Groups of normal mice were subcutane-
ously implanted with a small biodegradable pellet containing either the GC cor-
ticosterone or the potent GC antagonist RU486. A third group of animals was left
untreated as controls. Thepellets release their incorporated drug at a fairly constant
rate of 10 Ftg/h for corticosterone, or 250 ng/h for RU486 over a 2-3 wk period.
3-5 d afterthe initiation of treatment, animals from each ofthese groups were killed
and thelymphocytes from theirvarious lymphoid organs were individually collected
and stimulated wtih optimum amounts of anti-CD3 in vitro. Fig. 2 provides theA
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FIGURE 1.
￿
TotalTCGF, IL-2, and IL-4 production by lymphocytes isolated from distinct mu-
rine lymphoid tissues. Lymphocytes isolated from mucosal and nonmucosal lymphoid tissues
ofnormal (C3H x BL/6)FI mice were activated in vitro with anti-CD3. 24 hlater, cell culture
supernatants were assayed spectrophotometrically (see MaterialsandMethods) forthetotalTCGF
(no blocking antibodies; E), for the relative amount of IL-2 activity (anti-IL-4-blocking anti-
bodies; O), forthe relative amount ofIL-4 activity (anti-IL-2-blocking antibodies; 40), and for
uninhibited lymphokine activity (both blocking antibodies; 0). (A) IL-2 and IL-4 profiles of
anti-CD3-activated peripheral lymphnodes(PLN), (B)spleen, (C)mesenteric lymphnodes(MLN),
and (D) Peyer's patch. (E) A graphic presentation of IL-2 and IL-4 in units ofbicactivity pro-
duced by anti-CD3-stimulated cultured lymphocytes from the four lymphoid tissues by visual
inspection ofviable indicator cells(see MaterialsandMethods). Note that the twoassaymethods
reveal the identical relationship in lymphokine profiles. IL-2 represents the dominant TCGF
producedby activatedlymphocytes in the spleen andperipheral lymphnodes, andIL-4 represents
themajorTCGF produced by activated Peyer'spatchlymphocytes. Similartypesofcomparisons
between assay methodshave been performedon numerous test supernatants with excellentagree-
ment between the spectrophotometric and microscopic assays.
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Relative IL-2 andIL-4 bi-
oactivity produced bylymphocytes iso-
latedfrom thevariouslymphoid organs
of (A) normal C3H mice, and (B)
normal mice implanted with a bio-
degradable pellet containing the GC
hormone corticosterone 2 d before
deathandlymphocyte isolation, or (C)
normal mice implanted with a bio-
degradable pellet containing thepotent
GC antagonist RU486. An analysis of
IL-2 andIL-4 bioactivity in test super-
natants was made 24 h after in vitro
stimulation of lymphocytes with op-
timum amounts of anti-CD3. The in
vivo effects of corticosterone and
RU486, on subsequent lymphokine
production by activated lymphocytes
isolated from treatedanimals, hasbeen
determined in at least three different
experiments, andis foundto be highly
reproducible.
resultsofa representative experiment where the supernatants from each individual
culture were quantitatively analyzed for the presence of IL-2 and IL-4. The results
of this experiment demonstrate that systemic elevations in GC levels in vivo can
significantly alterthe potential for TCGF production by lymphocytes obtained from
allof theevaluated lymphoid compartments. Regardless ofcell source, activatedlym-
phocytes from GC-treated donors produced IL-4 as the predominant TCGF Sys-
temic treatment of normal mice with the potent GC antagonist RU486 appeared
to have alimited, although highly reproducible, effect on the lymphocytesobtained
from the mucosal lymphoid tissues only. The capacity of stimulated lymphocytes
obtained from the mesenteric lymph nodes or Peyer's patches to produce IL-2 was
consistently enhanced by a systemic RU486 treatment of the donor animals.
We recently found that a direct GC treatment of heterogeneous populations of
lymphoid cells, enriched T cells, T cell hybridomas, or cloned T cell lines, beforetheir activation with antigens or mitogens, resulted in a marked shift in the patterns
of TCGF capable of being synthesized and secreted (13). This led us to question
whether similar susceptibilities to GC-mediated influences existed in lymphocytes
obtained from various types of lymphoid tissues. Normal mice served as donors of
peripheral lymph nodes, spleen, mesenteric lymph node, and Peyer's patch lympho-
cytes. Cells from each population were divided into three aliquots, and one was ex-
posed for 30 min to 10-6 M corticosterone and another to 10' M RU486 before
extensive washingto remove all exogenous steroid hormone. The cell cultures were
then adjusted to 10' cells/ml and identically stimulated with anti-CD3. The results
(Fig. 3) demonstrated that exposure ofalllymphoid cell sourcesto GC in vitro resulted
in areductionin their capacity to secrete IL-2 in a concomitant increase in the produc-
tion of the TCGF IL-4 (Fig. 3 B) . The effect caused by RU486 treatment in vitro
was modest, with small enhancements observed in the production of IL-2 by both
the spleen and Peyer's patch lymphocytes.
Antigen-primed TCellsSwitch theirPotentialforProducing TCGF when in Particular Lym-
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Thedirect effects ofGCs
and RU486 on the relative IL-2 and
IL-4 activity measured in culture su-
pernatants of lymphocytes derived
from distinct murine lymphoid tissues.
Lymphocytes isolated from mucosal
and nonmucosal lymphoid tissues of
normal (C3H x BL/6)F1 mice were
stimulated with anti-CD3. 24 h later,
cell supernatants were assayed for the
relative activity ofIL-2 andIL-4by vi-
sual inspection ofthe indicatorcell line
(see Materialsand Methods).(A) Anti-
CD3 activation of lymphocyte popu-
lations obtained from normal mice and
(B)lymphocytes isolated from normal
mice cocultured with anti-CD3 after
a 30-min pulse with corticosterone
(10-6 M). (C) Anti-CD3-activated
lymphoid cells from normal mice
where cells were exposed to a 30 min
pulseof 10-7 M RU486. TheIL-2 and
IL-4 profiles of activated lymphocytes
from the different lymphoid tissues
have been assessed numerous times
with equivalent results.986
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￿
The secretion of IL-2 andIL-4 by OVA-primed lymphocytes isolated from various
lymphoid organs after antigen activation in vitro. Groups of C3H mice were immunized 3 wk
previously with OVA. (A) Thebioactivities ofIL-2 and IL-4 produced by OVA-stimulated lym-
phocytes from the lymphoid tissues ofnormal mice with acomparison betweenthespectrophoto-
metric and themicroscopic methodsforspleen. (B) Thebioactivities of IL-2 andIL-4 produced
by OVA-stimulated lymphocytes from animals implanted with a biodegradable corticosterone
pellet (designedto releaseGCsat arate of-12.5 Wg/d)5d before immunization. Acomparison
between spectrophotometric and microscopic methods for the spleen is also provided (see Fig.
1). This specific analysis ofantigen-induced IL-2 and IL-4 production by the various lymphoid
tissues has been performedtwicewith excellent agreementin experimental results between studies.
phoidOrgans.
￿
Normal mice were immunized with the antigen OVA, and their lym-
phoidorgans removed after 3 wk foranalysis of antigen-induced TCGF production.
The results of these assays (Fig. 4 A) determined that the relationship between IL-2
and IL-4 activity produced by isolated lymphocytes in response to antigen was com-
parable with that observed after an anti-CD3 stimulation of similar tissues isolated
from normal mice (e.g., IL-2 represented the dominant TCGF activity produced
by peripheral lymphoid tissuesand IL-4 was the predominantPeyer'spatch TCGF).
Analysis of the IL-2 and IL-4 titers produced by OVA-activated T cells, isolated from
animals that were immunized with antigen while under the systemic influence of
GCs, further established that IL-4 now represented the predominant TCGF pro-
duced from all lymphoid compartments (Fig. 4 B). Collectively, these results are
consistent with the hypothesis that while the specificity of antigen responsiveness
by Th cells is regulated through specific recognition by the TCR, the capacity of
these cells to produce lymphokines (at least TCGF, IL-2, and IL-4) may be con-
trolled through influences provided within a given tissue microenvironment. Fur-DAYNES ET AL.
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ther, these inherent influences appear to be susceptible to change by systemic endo-
crine effects caused directly by elevations in plasma levels ofGC hormones (effects
that appear to diminish the production of IL-2, and augment the production of IL-4
[13]).
Our results, so far, failed to discount the possibility that the differences we ob-
served in TCGF production were being mediated through the selective recruitment
ofT cell subsets into mucosal or nonmucosal lymphoid organs, with distinct subsets
having a precommitted potential for a dominance in IL-2 or IL-4 production after
cellular activation. In an attemptto question this possibility, peripheral lymph node
lymphocytes, spleniclymphocytes, and Peyer'spatchlymphocytes were collected from
agroupofOVA-primed donors 3 wk after their immunization with antigen. Stimu-
lation of an aliquot from each of these isolated cell populations with OVA in vitro
determined that theircapacity to produce IL-2 and IL-4 was similar to that presented
in Fig. 4, where IL-2 dominated theTCGF activity in supernatants from peripheral
lymph nodes and spleen, and IL-4 dominated the TCGF activity from the Peyer's
patch lymphocytes (data not shown). Each of these cell populations was adoptively
transferred into individual groups ofsyngeneic normal recipients, and the adoptive
recipients rested for a period of 1 wk before death for analysis of their lymphoid
compartments for TCGF production in response to in vitro OVA stimulation. The
results ofthis experiment (Fig. 5) determined that antigen-primed lymphocytes from
all three donor tissues (lymph node, spleen, and Peyer's patch) could gain access
into both the mucosal and nonmucosal lymphoid tissues of normal recipients, and
that the pattern of TCGF production by the lymphocytes obtained from any given
tissue appeared to be underinfluences being exerted by the lymphoid compartment
of the recipient, not the donor. These results suggest that the preferential synthesis
andsecretion ofeither IL-2 or IL-4 by antigen-activated Tcells obtained from primed
donors does not appear to be due to aprecommitment in functional potential being
exhibitedby theadoptively transferred donorcells. Rather, it appears that themucosal
lymphoid environmentis highly conducive to Tcell production of IL-4. Conversely,
recirculating T cells that have gained temporary residence in peripheral lymphoid
organs were apparently provided with environmental influences that enhance their
ability to produce IL-2 after response to antigen (or mitogen) activation.
TheNormal Androgen SteroidDHEA Enhances the Potential ofNormal TCells to Produce
IL-2. We recently demonstrated that the adrenal androgen steroidhormone DHEA
could exert direct effects on purified T cells, Tcell hybridomas, and antigen-specific
T cell clones (18). These effects were manifest as a marked increase in the capacity
of activated T cells to produce IL-2, plus the ability of DHEA to overcome the sup-
pressive influences ofGCs on the production ofthis TCGF DHEA sulfate was without
an effect in these in vitro systems (18).
To evaluate the possible role(s) played by this androgen steroid in vivo, normal
mice were injected intraperitoneallywith either 200lAg ofDHEA or 200pg ofDHEAS
3-7 d before death. The peripheral lymph nodes (axillary, brachial, and inguinal),
spleen, and Peyer's patches were collected from the two experimental groups, plus
from agroup ofnormal untreatedcontrols. Each individual cell population wasstimu-
lated with an optimum amount of anti-CD3, and the supernatants were analyzed
for IL-2 and IL-4 after 24 h. The results of a representative experiment (Fig. 6)
demonstrates that both DHEA and DHEA-sulfatase (when administered in vivo)988
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FIGURE 5. OVA-induced IL-2
and IL-4 TCGF production by
lymphocytes isolated from mucosal
and nonmucosal lymphoid organs
of (C3H x BL6)Fl adoptive re-
cipients of 5 x 107 (A) peripheral
lymph node lymphocytes, (B)
spleen, or(C)Peyer's patchlympho-
cytes obtained from syngeneic
OVA-primed donors. The adoptive
recipients were rested for 1 wk to
allowthe"memory" Tcellsto fully
equilibrate within the recirculating
Tcell pool, before death, isolation
of their lymphoid organs, and in
vitrostimulation oftheirlymphoid
cells to produce IL-2 and/or IL-4
in response to OVA. While partsof
this experiment have been repro-
duced several times, the experi-
ment, as presented in this figure,
hasbeen performedtwice with equiv-
alent results.
were capable of enhancing the ability of lymphocytes isolated from either the pe-
ripheral lymph nodesor spleen to produce IL-2 after activation. Only DHEA, how-
ever, was able to enhance the production of IL-2 by cells isolated from the Peyer's
patchesof treated animals. This consistent finding suggested that differentlymphoid
organs mightcontain varyinglevels of the enzyme DHEA-sulfatase, assuming DHEA
represents the active metabolite. When such studieswere performed (data not shown),
we found that DHEA-sulfatase activity (pmol DHEA produced/mg protein/h) was
high in the spleen and lymph nodes and low in Peyer's patches (60-80% reduced).
TheAbility of T Cells to Produce IL-2 or IL-4 after Stimulation is Directly Influenced by
theLymphoid Tissuefrom which they Were Isolated and Correlates with their DHEA-Sufatase
Content. Our finalexperiments were designed to thoroughly question the relation-
ship between the type of tissue (mucosal versus nonmucosal) that provides drainage
to a particular lymphoid organ, and the ability of lymphocytes collected from thatA
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given 200 ug ofeither DHEA or DHEAS by
intraperitonealinjection 3 d before prepara-
tion oftheirindicatedlymphoid cells for cul-
ture. Standard culture conditions, usingop-
timum amounts ofanti-CD3 forstimulation,
are as described in Materialsand Methods.
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lymphoid organ to produceTCGF after activation. In addition, each ofthe test tissues
was also simultaneously evaluated for DHEA-sulfatase enzymatic activity.
Groups of normal mice served as donors ofcervical, axillary, brachial, parathymic,
periaortic, inguinal, andmesenteric lymph nodes, spleen, and Peyer's patches. Each
tissue type was individually collected, and dissociated tissues were analyzed for the
capacity to secrete IL-2 and IL-4 after activation, or for DHEA-sulfatase activity.
The results ofthesestudiesarepresentedin TableI, and demonstrate that thequan-
titative relationship between the activities of IL-2 and IL-4 produced by lympho-
cytesin response to polyclonal T cell stimulation is directly relatedto the tissue (mucosal
vs. nonmucosal) that provides drainage to thelymphoid organbeingevaluated. Lym-
phocytes isolated from lymphoid organs receivingtheirafferent lymphatic drainage
from mucosal tissues (e.g., the cervical, parathymic, and periaortic lymph nodes,
and the Peyer's patches) predominantly produced IL-4 after the activation in vitro.
Conversely, lymphoid tissues receiving their drainage predominantly or exclusively
from nonmucosal sites (e.g., the axillary, brachial, and inguinal lymph nodes and990
TABLE I
Relationship between Inducible TCGF Production by Lymphocytes Derivedfrom
Various Murine Lymphoid Organs to their Expression of DHEA-Sulfatase Activity
LYMPHOID TISSUE CONTROL OF INTERLEUKIN
* Assay for IL-2 and IL-4 used the microscopic endpoint analysis. See Materials and Methods.
I DHEA-sulfatase activity was analyzed on homogenates of whole tissues . Additional enzyme assays have
determined that removal of erythrocytes from the spleen tissue by 0.83% ammonium chloride treatment
results in DHEA-sulfatase levels that are 1 .7-2 times greater than reported here.
spleen), predominantly produced IL-2 after activation. In addition, the ability of
lymphocytesobtained from a particular tissue to produce the TCGF IL-2 appeared
to be directly related to the amount ofDHEA-sulfatase activity present within the
particular tissue. Recent studies using purified lymphoid cell populations have de-
termined that macrophages are the major contributors to the DHEA sulfatase ac-
tivity (data not shown).
Discussion
Recognition of peptide antigens in the context of developmentally selected self
MHC molecules, and the activation ofantigen-specific clones ofT cells, represent
essential components in the afferent phase of an adaptive immunologic response.
Establishingprotective immunity to infectious agents or tumors, however, possesses
a number ofadditional requirements that extend far beyond the mechanisms ofan-
tigen recognition and lymphocyte activation . Recent investigations have determined
thatthe patternofdistinct speciesoflymphokines, which aresynthesized and secreted
by activated T cells, may play a pivotal role in directingthe development ofdistinct
types of immune effector responses (3). Logically, therefore, any mechanisms or
influences that function to regulate the pattern of lymphokines that are produced
by antigen-activated T cells would have important consequences on the types ofim-
mune responses initiated.
In animals, the majority of immunologic responses are initiated within the ana-
tomical confines ofa particular secondary lymphoid organ. It isaccepted that antigen-
reactive lymphocytes are activated in lymphoid organs in response to free antigen
or accessory cell-associated antigen peptides that enter the organ through either
afferent lymphatic drainage (e.g., lymph nodes), across gut mucosa (e.g., Peyer's
patches), or directly from the blood (e.g., spleen). The secondary lymphoid organs
ofmammals are fixed, widely distributed throughoutthe body, and are unique from
Lymphoid tissue
Major
tissue drainage IL-2/IL-4* DHEA sulfatase activityl
U/ml pmol DHEA/ms protein/h
Cervical lymph node Mucosal 1 :32 (4:128) 52
Axillary lymph node Nonmucosal 8:1 (128:16) 294
Brachial lymph node Nonmucosal 16:1 (256:16) 310
Parathymic lymph node Mucosal 1 :4 (4:16) 107
Periaortic lymph node Mucosal 1 :16 (4:64) 112
Spleen Nonmucosal 4:1 (128:32) 170
Inguinal lymph node Nonmucosal 8:1 (128:16) 190
Mesenteric lymph node Mucosal + nonmucosal 2:1 (64:32) 134
Peyer's patch Mucosal 1 :16 (1 :16) 47DAYNES ET AL.
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one another. This uniqueness is supported both anatomically and histologically, and
isprobably relatedto the differentfunctions that the varioustypesoflymphoidorgans
are believed to serve in the context ofthe overall immune system. Most evident are
the distinct types ofimmunologic responses that are necessary to provide irnmuno-
logic protection to either mucosal or nonmucosal tissue sites. Therefore, in spite
of the knowledge that the vast majority of mature T cells are in the recirculating
T cellpool andare fullycapableofextravasation or entry into all types ofsecondary
lymphoid organs (26), the selection ofone form ofimmunologic response over an-
other appears to exhibit a fair degree of anatomic compartmentalization.
The present study sought to question the possible consequences associated with
T cell compartmentalization into distinct types ofsecondary lymphoid organs with
regards to the types ofTCGFs capable ofbeing produced after antigen or mitogen
stimulation. Wereproducibly foundthat antigen- ormitogen-stimulated T cellsiso-
lated from peripherallymph nodes (axillary, brachial, inguinal) orthe spleen secreted
IL-2 asthe dominant TCGF, whileactivated Tcells, isolatedfromthe Peyer'spatches
ofnormal donors, produced IL-4 almost exclusively. Systemic treatment ofnormal
mice withGCs, orpotent GC antagonists, qualitatively alteredthe speciesofTCGF
capable of being produced by activated lymphocytes obtained from both mucosal
andnonmucosal lymphoidorgans. GC hormonetreatment resulted inIL-4 represent-
ing the dominant species of secreted TCGF from all lymphoid organs, while treat-
ment of mice with RU486 resulted in IL-2 secretion being dominant in all tested
organs afteractivation. We also observed that a direct exposure ofnormal lymphoid
cells tothe influences ofGCs orGC antagonists in vitro was capableofaltering their
potential to produceTCGF. Theseobservations providedadditional support forthe
concept that steroid hormones are able to exert both qualitative and quantitative
influences over the ability ofT cells to produce certain lymphokines, and reduced
the possibility that tissue selective homingofTcells was responsible forthe observed
differences in TCGF production found in various lymphoid compartments.
Determiningthat the adoptive transferofeither antigen-primed peripherallymph
nodelymphocytes (IL-2 dominant), spleniclymphocytes(IL-2 dominant), orPeyer's
patchlymphocytes (IL-4dominant) intonormal syngeneic recipients resulted intissue-
associated TCGF responses in the recipients that were identical to those observed
in the originaldonors, provided strong suggestiveevidence thatthe lymphoid organs
themselves were exerting some regulatory influenceoverthepatternofTCGFs capable
of being produced by their resident T cells.
Our recent work with the normal androgen steroid DHEA established that this
hormone had a strong positive influence on the ability of T cells to produce IL-2
after activation (18). DHEA represents the majoradrenal steroid produced byhumans
between their second and fifth decades of life (14, 16), and is uniquely sulfated to
DHEA-sulfate before secretion into the plasma (29). Unlike DHEA, DHEA-sulfate
is incapable of affecting TCGF production by lymphocytes directly exposed to the
hormone in vitro (18). Interestingly, DHEA wasveryeffectivein vivoin augmenting
the capacity ofisolated peripheral lymph node, spleen, and Peyer's patch lympho-
cytes to produce IL-2 after activation, while DHEA-sulfate was found to only be
active onperipheral lymphnode and spleen lymphocytes (Fig. 6). This reproducible
observation suggested that DHEA represented the active hormone metabolite and
that the desulfationofDHEA-sulfate to DHEAmightdisplayaleveloftissue specificity.992
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Various murine tissues have been quantitatively analyzed for DHEA sulfatase ac-
tivity (30), and lymph nodes and spleen have been described as tissues having high
levels of this enzyme. No reports exist concerning the DHEA-sulfatase activity of
murine Peyer's patches.
By undertaking a majorcomprehensive study on the secondary lymphoid organs
ofnormal mice, we were able to experimentally support our working hypothesis of
a lymphoid tissue control over T cell lymphokine production after activation. The
results ofthese studies determined that all ofthe isolated lymphoid organs that are
known to receive drainage from nonmucosal tissues contain T cells that predomi-
nantly produce IL-2 after activation . Conversely, all lymphoid organs that receive
theirdrainage from mucosal tissue sites were found to produce IL-4 as thepredomi-
nant TCGF (Table I). These results were paralleled by quantitative enzymaticanal-
yses ofthe DHEA-sulfatase activity present within the various types ofmurine lym-
phoid tissues. We established that a direct correlation existed between the tissue
DHEA-sulfatase content and thepresence ofan IL-2 dominance to TCGF produc-
tion by activated lymphocytes from a particular organ. Such a correlation provided
strong suggestive evidence that DHEA might be responsible in vivo for providing
recirculating T cells that are temporarily localized within lymphoid organs drained
by nonmucosal tissues, with the ability to produce IL-2 as their dominant TCGF.
We envision that adrenal DHEA-sulfate is being locally metabolized to DHEA by
tissue-associated DHEA-sulfatase. Paracrine effects ofDHEA on tissue localized T
cells wouldprovidethemwith anenhanced potentialto secrete IL-2 when activated.
Lymphoid tissues having sufficiently high levels ofDHEA-sulfatase activity would,
therefore, represent themicroenvironmentsmost conducivetoT cell IL-2 synthesis.
Lymphoid tissues that are known to receive drainage from mucosal tissue sites
were found to possess the lowest DHEA-sulfatase activity, and T cells from these
lymphoid organs produced IL-4 asthedominantTCGF Whetherthelack ofsufficient
DHEA-sulfatase activity in these lymphoid organs is, itself, responsible for the re-
producible observation of IL-4 dominance in TCGF production is presently un-
known. It is important to state that DHEA-sulfatase levels, and not the expression
ofperipherallymph node- (31)or Peyer's patch-specific (32)homingreceptors, served
as an accurate indicator ofwhether IL-4 orIL-2 would dominateTCGF production
(data not shown).
It is conceivable that the opposing hormonal influences ofDHEA and GCs on
T cells could account forthe wide variations in potential for TCGF production ob-
served in the various types of lymphoid organs. Alternatively, and representing a
mechanism that we presently favor, there may exist another speciesofhormone that
is capable ofexerting a paracrine influence, predominantly on T cells temporarily
localized within lymphoid organs being drained by mucosal tissues. We believe that
1,25-dihydroxyvitamin D3 [1,25(OH)2D3] may represent such a hormone. 1,25-
(OH)2D3 is the active hormone for which intracellular receptors are known to exist
in Tcells (33, 34). It is a metabolite of25-hydroxyvitamin D3, and can be produced
locally by the action of lct-hydroxylase (an enzyme that is inducible in LPS- or
IFN-,y-stimulated macrophages) (35, 36). 1,25(OH)2D3 has already been reported
to inhibitTcell production ofIL-2 and IFN-1' (37, 38), andwe have recently deter-
mined that this steroid hormone is a potent enhancer ofIL-4 production by acti-
vated T cells (Araneo, B. A., and R. A. Daynes, unpublished observations).DAYNES ET AL.
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Our present research has provided us with the information necessary to develop
a model to explain the differences that exist in individual lymphoid organs (related
to the potentialpossessedby theirrecirculating T cells for TCGF production if acti-
vated). Ourobservations suggest that thevast majority ofrecirculating Tcellspossess
the geneticpotential to produce both IL-2 and IL-4 afteractivation. Transient con-
trolling influences on TCGF production are epigenetically provided to individual
T cells during their short residence within a particular lymphoid tissue. These
influences appear to come from distinct species of steroid hormones, produced lo-
cally from inactive circulating precursors and acting in a paracrinemanner. Steroid
hormones are well known for their ability to function as transcriptional regulators
of gene activity, with individual species being capable of exerting both enhancing
and repressing influences on particular cellular genes (39). Our model implies that
individual recirculating T cells continually undergo phase variations, in potential
for lymphokine production, and are dependent upon microenvironmentally sup-
plied influences. T cells that are resident within lymphoid organs drained by non-
mucosaltissues would be in one phase where IL-2 would represent the predominant
TCGF produced after activation. Conversely, T cells in transit through lymphoid
organs drainedby mucosal tissues wouldbe placed in another phase, and IL-4 would
predominate TCGF production. How many other T cell lymphokines are suscep-
tible to this type of regulation is presently unknown. However, preliminary studies
indicate that the regulation of IFN-y exhibits similarities to the control of IL-2 by
steroidhormones. Further, IL-4 and IL-5 production also appearsto be coordinately
regulated by influences provided by steroid hormones (Araneo, B. A., and R. A.
Daynes, unpublished observations). Finally, our model possesses an additional im-
portant component. We hypothesize that the macrophage, already known to enter
lymphoid organs predominantly through the afferent lymphatic drainage from the
tissue sites(40), mayplay an extremelyimportant immunologic role beyond antigen
uptake, processing, and presentation. It is quite possible that the macrophage, as
a consequence of inductive influences provided during its surveillance of peripheral
or mucosal tissue sites, actually instructs the antigen-responsive T cell to produce
specific species of lymphokines after its entrance into the draining lymphoid organ
and its interaction with an antigen-responsive T cell. The actual instruction would
come from epigenetically facilitated transcriptional or post-transcriptional regula-
tory influences exerted by unique species of steroid hormones present within the
lymphoid tissue microenvironment. These functional steroid hormones would be
produced locally, or enter through the afferent lymphatic drainage from inactive
precursors metabolized by macrophage-associated enzymes.
Summary
We investigated thecapacity ofmurine T lymphocytes, isolated from variouslym-
phoid organs of normal or antigen-primed donors, to produce IL-2 or IL-4 after
activation with anti-CD3 or specific antigen. Our results established that T cells
resident within lymphoid organs being drained by nonmucosal tissue sites (e.g., ax-
illary, inguinal, brachial lymphnodes, or spleen)produced IL-2 as the predominant
Tcell growth factor (TCGF) after activation. Conversely, activated Tcells from lym-
phoid organs being drained by mucosal tissues (Peyer's patches, and cervical, peri-
aortic, and parathymic lymph nodes) produced IL-4 as the major species ofTCGR994
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Analysis ofthe lymphoid tissues obtained from adoptive recipients of antigen-primed
lymphocytes provided by syngeneic donors provided evidence that direct influences
were being exerted on T cells during their residence within defined lymphoid com-
partments. These lymphoid tissue influences appeared to be responsible for altering
the potential of resident T cells to produce distinct species of TCGF. Steroid hor-
mones, known transcriptional enhancers and repressors of specific cellular genes,
were implicated in the controlling mechanisms over TCGFproduction. Glucocorti-
coids (GCs) were found to exert a systemic effect on all recirculating T cells, evi-
denced by a marked dominance in IL-4 production by T cells obtained from all
lymphoid organs ofGC-treated mice, or after a direct exposure ofnormal lymphoid
cells to GCs in vitro before cellular activation with T cell mitogens. Further, the
androgen steroid DHEA appeared to be responsible for providing an epigenetic
influence to T cells trafficking through peripheral lymphoid organs. This steroid
influence resulted in an enhanced potential for IL-2 secretion after activation. Ana-
tomic compartmentalization of the DHEA-facilitated influence appears to be medi-
ated by differential levels of DHEA-sulfatase in lymphoid tissues. DHEA-sulfatase
is an enzyme capable of converting DHEA-sulfate (inactive) to the active hormone
DHEA. We find very high activities ofthis enzyme isolated in murine macrophages .
The implications ofour findings to immunobiology are very great, and indicate that
T cells, while clonally restricted for antigen peptide recognition, also appear to ex-
hibit an extreme flexibility with regards to the species of lymphokines they produce
after activation .
Regulation of this highly conservative mechanism appears to be partially, if not
exclusively, controlled by cellular influences being exerted by distinct species of ste-
roid hormones, supplied in an endocrine or a paracrine manner where they mediate
either systemic or tissue-localized influences, respectively. Our results also suggest
that macrophages, known to primarily enter peripheral lymphoid organs through
afferent lymphatic drainage, might be responsible for both antigen presentation,
as well as being major contributors to the controlling influenceson a T cell's capacity
for lymphokine production.
Receivedfor publication 26 October 1989.
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